Boston Scientific (NYSE:BSX) Coverage Initiated by Analysts at The Goldman Sachs Group

Equities researchers at The Goldman Sachs Group assumed coverage on shares of Boston Scientific (NYSE:BSX – Get Free Report) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm set a “buy” rating and a $90.00 price target on the medical equipment provider’s stock. The Goldman Sachs Group’s target price would indicate […]

Related Keywords

Boston ,Massachusetts ,United States ,John Bradley Sorenson ,Charlesj Dockendorff ,Investment Counselors ,Riverpark Advisors ,Boston Scientific Company Profile ,Eagle Bay Advisors ,First Foundation Advisors ,Securities Exchange Commission ,Deutsche Bank Aktiengesellschaft ,Boston Scientific ,Goldman Sachs Group ,Boston Scientific Corporation ,Investment Advisors Inc ,Jpmorgan Chase Co ,Get Free Report ,Bradley Sorenson ,Exchange Commission ,Director Charles ,Foundation Advisors ,Bay Advisors ,Park Advisors ,Scientific Corporation ,Boston Scientific Daily ,